Early research (Phase 1)Study completedNCT00110578
What this trial is testing
Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24